(ALV) Allianz SE VNA O.N. - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE0008404005
Stock:
Total Rating 35
Risk 59
Buy Signal -0.38
| Risk 5d forecast | |
|---|---|
| Volatility | 16.0% |
| Relative Tail Risk | 3.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.68 |
| Alpha | 12.36 |
| Character TTM | |
|---|---|
| Beta | 0.336 |
| Beta Downside | 0.495 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.03% |
| CAGR/Max DD | 2.46 |
EPS (Earnings per Share)
Revenue
Description: ALV Allianz SE VNA O.N.
Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services Internationally. The company's Property-Casualty segment offers various insurance products, including motor liability, accident, fire and property, legal expense, credit, and travel to private and corporate customers. Its Life/Health segment provides a range of life and health insurance products on an individual and a group basis, such as annuities, endowment and term insurance, and unit-linked and investment-oriented products, as well as private and supplemental health, and long-term care insurance products. The company's Asset Management segment offers institutional and retail asset management products and services to third-party investors comprising equity and fixed income funds, cash, and multi-assets; and alternative investment products that include real estate, infrastructure debt/equity, real assets, and liquid alternatives. Its Corporate and Other segment provides banking services for retail clients, as well as digital investment services. Allianz SE was founded in 1890 and is headquartered in Munich, Germany.
Altman Z''
Beneish M
| DSRI: none (Receivables none/8.08b, Revenue 186.90b/130.52b) |
| GMI: 0.89 (GM 100.0% / 88.50%) |
| AQI: none (AQ_t none / AQ_t-1 none) |
| SGI: 1.43 (Revenue 186.90b / 130.52b) |
| TATA: none (NI 10.78b - CFO 36.77b) / TA none) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of ALV shares?
As of March 02, 2026, the stock is trading at EUR 382.20 with a total of 1,282,600 shares traded.
Over the past week, the price has changed by +0.90%, over one month by +0.79%, over three months by +3.38% and over the past year by +17.16%.
Over the past week, the price has changed by +0.90%, over one month by +0.79%, over three months by +3.38% and over the past year by +17.16%.
Is ALV a buy, sell or hold?
Allianz SE VNA O.N. has no consensus analysts rating.
What are the forecasts/targets for the ALV price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 365 | -4.5% |
| Analysts Target Price | - | - |
ALV Fundamental Data Overview February 28, 2026
Market Cap USD = 165.24b (140.11b EUR * 1.1794 EUR.USD)
P/E Trailing = 13.9447
P/E Forward = 12.4069
P/S = 1.3517
P/B = 2.4295
P/EG = 1.5316
Revenue TTM = 186.90b EUR
EBIT TTM = 14.44b EUR
EBITDA TTM = 14.65b EUR
Long Term Debt = 66.15b EUR (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 140.11b EUR (140.11b + (null Debt) - (null CCE))
Interest Coverage Ratio = 1.0 (Ebit TTM 14.44b / Interest Expense TTM 14.44b)
EV/FCF = 4.02x (Enterprise Value 140.11b / FCF TTM 34.83b)
FCF Yield = 24.86% (FCF TTM 34.83b / Enterprise Value 140.11b)
FCF Margin = 18.64% (FCF TTM 34.83b / Revenue TTM 186.90b)
Net Margin = 5.77% (Net Income TTM 10.78b / Revenue TTM 186.90b)
Gross Margin = unknown ((Revenue TTM 186.90b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 140.11b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense -376.0m / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 10.83b (EBIT 14.44b * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 14.65b)
Debt / FCF = unknown (Net Debt none / FCF TTM 34.83b)
Total Stockholder Equity = 60.02b (last 4 quarters mean from totalStockholderEquity)
RoA = unknown (Net Income 10.78b / Total Assets none)
RoE = 17.95% (Net Income TTM 10.78b / Total Stockholder Equity 60.02b)
RoCE = 11.44% (EBIT 14.44b / Capital Employed (Equity 60.02b + L.T.Debt 66.15b))
RoIC = 15.80% (NOPAT 10.83b / Invested Capital 68.53b)
WACC = 7.15% (E(140.11b)/V(140.11b) * Re(7.15%) + (debt-free company))
Discount Rate = 7.15% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 84.08% ; FCFF base≈30.16b ; Y1≈37.21b ; Y5≈63.37b
[DCF] Fair Price = 3351 (EV 1291.98b - Net Debt 0.0 = Equity 1291.98b / Shares 385.6m; r=7.15% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 43.81 | EPS CAGR: -5.17% | SUE: 1.18 | # QB: 2
Revenue Correlation: 23.23 | Revenue CAGR: 19.76% | SUE: 0.18 | # QB: 0
EPS next Year (2026-12-31): EPS=31.10 | Chg7d=+0.530 | Chg30d=+0.566 | Revisions Net=+2 | Growth EPS=+7.9% | Growth Revenue=+4.2%
P/E Trailing = 13.9447
P/E Forward = 12.4069
P/S = 1.3517
P/B = 2.4295
P/EG = 1.5316
Revenue TTM = 186.90b EUR
EBIT TTM = 14.44b EUR
EBITDA TTM = 14.65b EUR
Long Term Debt = 66.15b EUR (from longTermDebt, two quarters ago)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 140.11b EUR (140.11b + (null Debt) - (null CCE))
Interest Coverage Ratio = 1.0 (Ebit TTM 14.44b / Interest Expense TTM 14.44b)
EV/FCF = 4.02x (Enterprise Value 140.11b / FCF TTM 34.83b)
FCF Yield = 24.86% (FCF TTM 34.83b / Enterprise Value 140.11b)
FCF Margin = 18.64% (FCF TTM 34.83b / Revenue TTM 186.90b)
Net Margin = 5.77% (Net Income TTM 10.78b / Revenue TTM 186.90b)
Gross Margin = unknown ((Revenue TTM 186.90b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 140.11b / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense -376.0m / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 10.83b (EBIT 14.44b * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 14.65b)
Debt / FCF = unknown (Net Debt none / FCF TTM 34.83b)
Total Stockholder Equity = 60.02b (last 4 quarters mean from totalStockholderEquity)
RoA = unknown (Net Income 10.78b / Total Assets none)
RoE = 17.95% (Net Income TTM 10.78b / Total Stockholder Equity 60.02b)
RoCE = 11.44% (EBIT 14.44b / Capital Employed (Equity 60.02b + L.T.Debt 66.15b))
RoIC = 15.80% (NOPAT 10.83b / Invested Capital 68.53b)
WACC = 7.15% (E(140.11b)/V(140.11b) * Re(7.15%) + (debt-free company))
Discount Rate = 7.15% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -1.91%
[DCF] Terminal Value 84.08% ; FCFF base≈30.16b ; Y1≈37.21b ; Y5≈63.37b
[DCF] Fair Price = 3351 (EV 1291.98b - Net Debt 0.0 = Equity 1291.98b / Shares 385.6m; r=7.15% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 43.81 | EPS CAGR: -5.17% | SUE: 1.18 | # QB: 2
Revenue Correlation: 23.23 | Revenue CAGR: 19.76% | SUE: 0.18 | # QB: 0
EPS next Year (2026-12-31): EPS=31.10 | Chg7d=+0.530 | Chg30d=+0.566 | Revisions Net=+2 | Growth EPS=+7.9% | Growth Revenue=+4.2%